Perjeta 420mg Injection: Powerful Treatment for Cancer Patients

Perjeta 420mg Injection

Uses:

• Treatment of HER2-positive breast cancer in combination with other chemotherapy medications.

Therapeutic Effects:

• Perjeta 420mg binds to the human epidermal growth factor receptor 2 (HER2) on cancer cells, potentially destroying or inhibiting cancer cell growth.

Interaction with Other Drugs:

• Inform your healthcare provider about all your medicines, including prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Perjeta 420mg and reduce effectiveness by causing undesirable side effects.

Safety Advice:

• Pregnancy: Inform your doctor if you are pregnant, think you might be pregnant, or are planning to get pregnant.
• Breastfeeding: Consult your doctor if you are breastfeeding before taking this medication.
• Lungs: Notify your physician if you have any lung disease before starting the treatment.
• Liver: Perjeta 420mg Injection is used with caution in patients with liver impairment. Inform your physician about the pre-existing liver conditions.
• Alcohol: It is not known whether it is safe to consume alcohol with Perjeta 420mg injection. Please consult your doctor.
• Driving: Perjeta 420mg injection may cause dizziness, infusion reaction, and other minor effects. So, avoid driving if you are unwell.

Storage:

• Keep Perjeta 420mg Injection out of sight and reach of children.
• Store in a refrigerator at 2°C to 8°C. Do not freeze.

Administration:

• Perjeta 420mg Injection is available as an injection and administered intravenously once every three weeks. Follow your physician's instructions. Your doctor will determine the frequency and dose of administration because it varies for each person depending on the disease condition. Do not self-administer.

Side Effects:

• Serious: Severe or persistent diarrhea, low white blood cell count, infusion reactions (fever, chills, hot flushes, nausea, headache, joint, and muscle pain), severe allergic reactions (swelling of throat and face, difficulty in breathing), heart problems (cough, swelling in arms or legs, shortness of breath), tumour lysis syndrome (confusion, tiredness, irregular heartbeat, seizures, tingling sensation).
• Common: Hair loss, rash, sore mouth, constipation, poor appetite, changes in taste, sleeping troubles, nose bleeds, heartburn, nail problems, producing more tears, feeling dizzy, dry and itchy skin, ear, nose, or throat infection.

Word of Advice:

• Perjeta 420mg can cause heart problems like heart failure, irregular heartbeats, and uncontrolled high blood pressure. So, inform your doctor about your medical history before starting with the treatment. If you experience any symptoms mentioned above, consult your doctor immediately. While undergoing treatment, use effective contraception and continue it for six months after stopping treatment.

FAQs:

1. Does Perjeta 420mg cause any heart problems?

   • Perjeta 420mg can damage the heart muscle and increase the risk of heart problems. Notify your doctor if you have any history of heart problems.

2. Should I use contraception even after the treatment with Perjeta 420mg?

   • Yes, using contraception during and after treatment with Perjeta 420mg injection for at least six months is necessary.

3. Can Pertuzumab be self-administered?

   • No, Pertuzumab should not be self-administered and must be given only under the supervision of a healthcare professional.

4. What should I tell my doctor before taking the Perjeta 420mg injection?

   • Inform your doctor about the history of your high blood pressure, irregular heartbeat, heart failure, and other heart-related problems.

5. Is it okay to take new medication while taking Perjeta 420mg?

   • Inform your doctor about the list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use because certain medications may interact with Perjeta 420mg and reduce effectiveness by causing undesirable side effects.

Fact Box:

• Molecule name: Pertuzumab
• Therapeutic class: Antineoplastics
• Pharmacological class: Monoclonal antibody (mAb)
• Indications: Treatment of HER2-positive breast cancer

Tags: perjeta, injection, 420mg, medical-drug, pharmacy, medicine, cancer-treatment